MLchartDataset catalogue

Long peptide vaccine 7

Term · Oncology and biomedicine · MLC-T-ONC-014881

A peptide vaccine consisting of a combination of seven synthetic long peptides (SLPs), which are each about 30 amino acids in size, and derived from cancer-testis antigens (CTA) and melanocytic differentiation proteins (MDP), with potential immunostimulating and antitumor activities. Upon administration, long peptide vaccine 7 may stimulate the host immune system to mount a cytotoxic T-cell lymphocyte (CTL) response against tumor cells expressing these peptides. CTA and MDP are overexpressed in a variety of cancer cell types.

Table 1. Record
IdentifierMLC-T-ONC-014881
FieldOncology and biomedicine
AbbreviationLPV7
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014881",
  "term": "Long peptide vaccine 7",
  "field": "Oncology and biomedicine",
  "definition": "A peptide vaccine consisting of a combination of seven synthetic long peptides (SLPs), which are each about 30 amino acids in size, and derived from cancer-testis antigens (CTA) and melanocytic differentiation proteins (MDP), with potential immunostimulating and antitumor activities. Upon administration, long peptide vaccine 7 may stimulate the host immune system to mount a cytotoxic T-cell lymphocyte (CTL) response against tumor cells expressing these peptides. CTA and MDP are overexpressed in a variety of cancer cell types.",
  "abbreviation": "LPV7",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/long-peptide-vaccine-7/"
}

Record 10,292 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.